S-8877 Sunitinib, Free Base, >99%

Related Terms : [SU-11248] [Sutent] [PHA-290940AD] [PNU-290940AD]

  • Size
  • US $
  • £
  • ¥
  • 300 mg
  • 44
  • 37
  • 32
  • 4,900
  • Add to Cart Qty:
  • In stock
  • 500 mg
  • 57
  • 48
  • 42
  • 6,300
  • Add to Cart Qty:
  • In stock
  • 1 g
  • 72
  • 61
  • 53
  • 7,900
  • Add to Cart Qty:
  • In stock
  • 2 g
  • 118
  • 100
  • 87
  • 13,000
  • Add to Cart Qty:
  • In stock
  • 5 g
  • 238
  • 201
  • 175
  • 26,300
  • Add to Cart Qty:
  • In stock

Note: Our Euro, Pound, and Yen prices are revised regularly to account for currency exchange rate fluctuations.

To receive a Quotation for catalog sizes of this product and/or any other products, please add them to your shopping cart and click on the “REQUEST A QUOTATION” box.
Click Here to Request a Quotation for Larger Quantities Free Shipping and Handling to the U.S. and 33 Other Countries
  • M.W. 398.47
  • C22H27FN4O2
  • [557795-19-4]
  • M.I. 14: 9000

Storage: Store at or below -20 ºC. Solubility: Soluble in DMSO at 40 mg/mL; soluble in ethanol at 1.4 mg/mL with warming; very poorly soluble in water; maximum solubility in plain water is estimated to be about 10-20 µM; buffers, serum, or other additives may increase or decrease the aqueous solubilit. Disposal: A.

View the SDS for this product

  • This is the free base form of sunitinib; please see our product Sunitinib, Malate Salt, Cat. No. S-8803, for further technical information. The malate salt form of sunitinib, not the free base, is used in the sunitinib formulation for use in humans.
  • Sunitinib (as the malate salt) is the active ingredient in the drug sold under the trade name Sutent. This drug is a small molecule receptor tyrosine kinase inhibitor that has been approved in at least one country for the treatment of patients having gastrointestinal stromal tumors or renal cell carcinomas. NOTE: The sunitinib malate sold by LC Laboratories is NOT Sutent®, and is NOT for human use.
  • Sold for laboratory or manufacturing purposes only; not for human, medical, veterinary, food, or household use.
  • This product is offered for R&D use in accordance with (i) 35 USC 271(e)+A13(1) in the U.S.; (ii) Section 69.1 of Japanese Patent Law in Japan; (iii) Section 11, No. 2 of the German Patent Act of 1981 in Germany; (iv) Section 60, Paragraph 5b of the U.K. Patents Act of 1977 in the U.K.; (v) Sections 55.2(1) and 55.2(6) and other common law exemptions of Canadian patent law; (vi) Section 68B of the Patents Act of 1953 in New Zealand together with the amendment of same by the Statutes Amendment Bill of 2002; (vii) such related legislation and/or case law as may be or become applicable in the aforementioned countries; and (viii) such similar laws and rules as may apply in various other countries.
  • Not available in some countries; not available to some institutions; not available for some uses.